Skip to main content
Clinical Trials/CTRI/2025/11/097174
CTRI/2025/11/097174
Not yet recruiting
Phase 2

Comparative Evaluation of dexmedetomidine versus dexamethasone as an adjuvant to bupivacaine in bilateral suprazygomatic maxillary nerve block for postoperative analgesia in children undergoing cleft palate surgeries : A Randomized, Prospective, Double-Blind Study

AIIMS New Delhi1 site in 1 country60 target enrollmentStarted: November 20, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
AIIMS New Delhi
Enrollment
60
Locations
1
Primary Endpoint
Time for first rescue analgesia

Overview

Brief Summary

This study is a randomized, prospective, double-blind clinical trial designed to compare the effectiveness of dexmedetomidine and dexamethasone as adjuvants to bupivacaine in bilateral suprazygomatic maxillary nerve blocks for providing postoperative analgesia in children undergoing cleft palate surgery. The aim is to evaluate which adjuvant offers superior pain relief, longer duration of analgesia, and better safety profile in the pediatric population, thereby contributing to improved postoperative outcomes and reduced need for systemic analgesics.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
8.00 Month(s) to 5.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Children posted for elective cleft palate repair under general anaesthesia Aged between 8 months to 5 years ASA category I and II Willing to give consent.

Exclusion Criteria

  • Lack of Parental consent Allergic to local anesthetics Coagulation disorders Local infection or lesion at the proposed puncture site Language difficulties Cognitive disorders Comorbid conditions like congenital heart diseases airway obstruction disease and central nervous system disorders.

Outcomes

Primary Outcomes

Time for first rescue analgesia

Time Frame: Time for first rescue analgesia 24 hours | duration of analgesia 24 hours

Duration of analgesia

Time Frame: Time for first rescue analgesia 24 hours | duration of analgesia 24 hours

Secondary Outcomes

  • Postoperative FLACC score(Total Postoperative fentanyl consumption)

Investigators

Sponsor
AIIMS New Delhi
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Amanpreet Singh

AIIMS New Delhi

Study Sites (1)

Loading locations...

Similar Trials